Search - tctmd.com

Displaying 61 - 80 of 91

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Presenter: William A. Gray, Gregg W. Stone, Matthew J. Price

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Random Musings on TMVR Pivotal Trial Designs

Presenter: Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Interventional Perspectives of TMVR: Addressing the Four Big Questions

Presenter: Martin B. Leon, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Surgical Perspectives of TMVR: Focus on Patient Selection and Clinical Management Issues

Presenter: Martin B. Leon, Gregg W. Stone, Michael J. Mack

June 22, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

Presentation Fellows 2018

NSTEMI Case Presentations With Discussion

Presenter: Duane S. Pinto, Ajay J. Kirtane, Nicholas J. Lembo, Jeffrey W. Moses, Gregg W. Stone

April 13, 2018

Presentation Fellows 2018

ACS Pharmacology for the Interventionalist

Presenter: Duane S. Pinto, Gregg W. Stone

April 13, 2018

Presentation Fellows 2018

The History of Reperfusion Therapies in STEMI: How Far Weve Come

Presenter: Duane S. Pinto, Gregg W. Stone

April 13, 2018

Presentation Fellows 2018

The Evolution of Drug-Eluting Stents

Presenter: Manish A. Parikh, Gregg W. Stone

April 13, 2018

News Conference News ACC 2018

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

Shelley Wood

March 15, 2018

News Conference News ACC 2018

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Yael L. Maxwell

March 12, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

Presentation JIM 2018

Overview of New Generation Drug-Eluting Stents

Presenter: Gregg W. Stone

February 22, 2018

News Daily News

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Yael L. Maxwell

February 20, 2018

Advertisement

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Random Musings on TMVR Pivotal Trial Designs

Interventional Perspectives of TMVR: Addressing the Four Big Questions

Surgical Perspectives of TMVR: Focus on Patient Selection and Clinical Management Issues

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Uncomplicated TLR After PCI Linked With Worse Mortality

NSTEMI Case Presentations With Discussion

ACS Pharmacology for the Interventionalist

The History of Reperfusion Therapies in STEMI: How Far Weve Come

The Evolution of Drug-Eluting Stents

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Update on PCI for LMCA and Multivessel Disease

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Overview of New Generation Drug-Eluting Stents

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content